Towards tropomyosin-related kinase B (TrkB) receptor ligands for brain imaging with PET: Radiosynthesis and evaluation of 2-(4-[18F] fluorophenyl)-7,8-dihydroxy-4H-chromen-4-one and 2-(4-([N-methyl-11C]-dimethylamino)phenyl)-7,8-dihydroxy-4H-chromen-4-one

被引:17
|
作者
Bernard-Gauthier, Vadim [1 ,2 ]
Boudjemeline, Mehdi [1 ]
Rosa-Neto, Pedro [3 ]
Thiel, Alexander [4 ]
Schirrmacher, Ralf [1 ,2 ]
机构
[1] Univ Montreal, Dept Chem, Stn Downtown, Montreal, PQ H3C 3J7, Canada
[2] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ H3A 2B4, Canada
[3] Douglas Mental Hlth Univ Inst, McGill Ctr Studies Aging, Translat Neuroimaging Lab, Verdun, PQ H4H 1R3, Canada
[4] McGill Univ, Jewish Gen Hosp, Dept Neurol & Neurosurg, Montreal, PQ H2T 1E2, Canada
基金
加拿大创新基金会;
关键词
Tropomyosin-related kinases B receptor; Positron emission tomography; 7,8-Dihydroxyflavone; Fluorine-18; Carbon-11; Radiochemistry; BETA-AMYLOID PLAQUES; NEUROTROPHIC FACTOR; ALZHEIMERS-DISEASE; P-GLYCOPROTEIN; MOUSE MODEL; FLAVONOIDS; 7,8-DIHYDROXYFLAVONE; EXPRESSION; PROBES; AGONIST;
D O I
10.1016/j.bmc.2013.10.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction of tropomyosin-related kinase B (TrkB) with the cognate ligand brain-derived neurotrophic factor (BDNF) mediates fundamental pathways in the development of the nervous system. TrkB signaling alterations are linked to numerous neurodegenerative diseases and conditions. Herein we report the synthesis, biological evaluation and radiosynthesis of the first TrkB radioligands based on the recently identified 7,8-dihydroxyflavone chemotype. 2-(4-[F-18]fluorophenyl)-7,8-dihydroxy-4H-chromen-4-one ([F-18]10b) was synthesized in high radiochemical yields via an efficient SNAr radiofluorination involving a para-Michael acceptor substituted aryl followed by BBr3-promoted double demethylation. Selective N-[C-11]methylation afforded 2-(4-([N-methyl-C-11]-dimethylamino) phenyl)-7,8-dihydroxy-4H-chromen4- one ([C-11]10c) from the fully deprotected catechol-bearing normethyl precursor 13 with [C-11]MeOTf. In vitro autoradiography of [F-18]10b with transverse rat brain sections revealed high specific binding in the cortex, striatum, hippocampus and thalamus in accordance with expected TrkB distribution. Blockade experiments with both 7,8-dihydroxyflavone (1a) and TrkB cognate ligand, BDNF, led to decreases of 80% and 85% of radioligand binding strongly supporting the hypothesis that 7,8-dihydroxyflavones exert their effect on TrkB phosphorylation via direct TrkB extracellular domain (ECD) binding. Positron emission tomography (PET) studies revealed that [F-18]10b and [C-11]10c brain uptake is minimal and that they are rapidly eliminated from the plasma (effective plasma half-life 5-10 min) via hepatic secretion. Nevertheless, the high specific binding and TrkB specificity derived from in vitro experiments suggests that the 7,8-disubstituted flavone chemotype represents a promising scaffold for the development of TrkB radiotracers for PET. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7816 / 7829
页数:14
相关论文
共 50 条
  • [41] Synthesis of a 2-nitroimidazole derivative N-(4-[18F]fluorobenzyl)-2-(2-nitro-1H-imidazol-1-yl)-acetamide ([18 F]FBNA) as PET radiotracer for imaging tumor hypoxia
    Nario, Arian Perez
    Woodfield, Jenilee
    dos Santos, Sofia Nascimento
    Bergman, Cody
    Wuest, Melinda
    Araujo, Yasniel Babi
    Lapolli, Andre Luis
    West, Frederick G.
    Wuest, Frank
    Bernardes, Emerson Soares
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2022, 7 (01)
  • [42] Synthesis of a 2-nitroimidazole derivative N-(4-[18F]fluorobenzyl)-2-(2-nitro-1H-imidazol-1-yl)-acetamide ([18 F]FBNA) as PET radiotracer for imaging tumor hypoxia
    Arian Pérez Nario
    Jenilee Woodfield
    Sofia Nascimento dos Santos
    Cody Bergman
    Melinda Wuest
    Yasniel Babí Araújo
    André Luis Lapolli
    Frederick G. West
    Frank Wuest
    Emerson Soares Bernardes
    EJNMMI Radiopharmacy and Chemistry, 7
  • [43] Synthesis and in vivo validation of [O-methyl-11C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin-yl]butyl}-4-methy1-2H-[1,2,4]triazine-3,5-dione:: A novel 5-HT1A receptor agonist positron emission tomography ligand
    Kumar, JSD
    Majo, VJ
    Hsiung, SC
    Millak, MS
    Liu, KP
    Tamir, H
    Prabhakaran, J
    Simpson, NR
    Van Heertum, RL
    Mann, JJ
    Parsey, RV
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (01) : 125 - 134
  • [44] Evaluation of [C-11]7-Chloro-2-[4-Methoxy-3-(2-(4-Methylpiperidin-1-Yl)ethoxy)phenyl]isoindolin-1-One as a PET Imaging Agent for 5-HT2C Receptors in the Nonhuman Primate Brain
    Goodman, Mark
    Zeng, Fanxing
    Nye, Jonathon
    Mun, Jiyoung
    Voll, Ronald
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 419 - 419
  • [45] Preclinical Imaging Evaluation of Novel TSPO-PET Ligand 2-(5,7-Diethyl-2-(4-(2-[18F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([18F]VUIIS1008) in Glioma
    Dewei Tang
    Michael L. Nickels
    M. Noor Tantawy
    Jason R. Buck
    H. Charles Manning
    Molecular Imaging and Biology, 2014, 16 : 813 - 820
  • [46] Preclinical Imaging Evaluation of Novel TSPO-PET Ligand 2-(5,7-Diethyl-2-(4-(2-[18F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([18F]VUIIS1008) in Glioma
    Tang, Dewei
    Nickels, Michael L.
    Tantawy, M. Noor
    Buck, Jason R.
    Manning, H. Charles
    MOLECULAR IMAGING AND BIOLOGY, 2014, 16 (06) : 813 - 820
  • [47] Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[18F]Fluoroethoxy)phenyl)-5-Methylpyrazolo[1,5-a]Pyrimidin-3-yl)-N,N-Diethylacetamide (18F-VUIIS1018A) to Image Glioma
    Dewei Tang
    Jun Li
    Michael L. Nickels
    Gang Huang
    Allison S. Cohen
    H. Charles Manning
    Molecular Imaging and Biology, 2019, 21 : 113 - 121
  • [48] Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[18F]Fluoroethoxy)phenyl)-5-Methylpyrazolo[1,5-a]Pyrimidin-3-yl)-N,N-Diethylacetamide (18F-VUIIS1018A) to Image Glioma
    Tang, Dewei
    Li, Jun
    Nickels, Michael L.
    Huang, Gang
    Cohen, Allison S.
    Manning, H. Charles
    MOLECULAR IMAGING AND BIOLOGY, 2019, 21 (01) : 113 - 121
  • [49] Synthesis and crystal structure of 4-(3-acetyl-5-(thiophen-2-yl)-2,3-dihydro-1,3,4-oxadiazol-2-yl)-7-(diethylamino)-2H-chromen-2-one, C21H21N3O4S
    Yu, Xiang
    Chen, Ya-Fang
    Huang, Guo-Juan
    Zhang, You-Fang
    Yang, Wu-De
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2020, 235 (03): : 561 - 562
  • [50] Evaluation of the novel TSPO radiotracer 2-(7-butyl-2-(4-(2-([18F]fluoroethoxy)phenyl)-5-methylpyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide in a preclinical model of neuroinflammation
    Tang, Dewei
    Fujinaga, Masayuki
    Hatori, Akiko
    Zhang, Yiding
    Yamasaki, Tomoteru
    Xie, Lin
    Mod, Wakana
    Kumata, Katsushi
    Liu, Jianjun
    Manning, H. Charles
    Huang, Gang
    Zhang, Ming-Rong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 150 : 1 - 8